Discover, Validate & Integrate More Specific CNS Biomarkers to Improve Early Detection, Enhance Precision Neuroscience & Reduce the Translational Bottleneck
As the only industry-driven forum focused exclusively on biomarker discovery and validation for neurodegenerative and neuroinflammatory diseases, the 3rd Fluid & Imaging Biomarkers in Neuroscience Summit unites biotech, pharma and academic scientists to transform diagnosis and monitoring of Alzheimer’s, Parkinson’s, ALS, and MS.
Join 80+ experts from Roche, Prothena, Eisai, Michael J. Fox Foundation and more to decode regulatory pathways, optimize IND timing, and harness breakthrough insights in p-tau217, alpha-synuclein, emerging omics platforms, and more.
As the field rapidly shifts toward blood-based diagnostics, high-sensitivity assays, and regulatory clarity, this is your unparalleled opportunity to collaborate with CNS biomarker leaders to shape a new wave of omics-based discoveries, surrogate endpoint success stories, pre-symptomatic detection technologies, and more.
"The diversity of topics and case studies stood out and very good coverage of both biofluids as well as imaging biomarkers"
Passage Bio
- 80+ Translational, Precision Neuroscience, Bioanalytical, Biomarker & Data Scientists Sharing Ground-Breaking Research & Strategies
- 1 Separately Bookable Pre-Conference Workshop Day
- 8+ Hours of Networking with 80+ Likeminded Peers
World-Class Speaker Faculty Includes:
80+
Biomarker
Scientists
3rd
Year Running
8+
Networking Hours
18+
Speakers
Previously Attending Companies Include:
Official Partners
Explore Related Events
